268 related articles for article (PubMed ID: 16809315)
21. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses.
Heer AK; Shamshiev A; Donda A; Uematsu S; Akira S; Kopf M; Marsland BJ
J Immunol; 2007 Feb; 178(4):2182-91. PubMed ID: 17277123
[TBL] [Abstract][Full Text] [Related]
22. Immunoprotective activity of a Salmonid Alphavirus Vaccine: comparison of the immune responses induced by inactivated whole virus antigen formulations based on CpG class B oligonucleotides and poly I:C alone or combined with an oil adjuvant.
Thim HL; Iliev DB; Christie KE; Villoing S; McLoughlin MF; Strandskog G; Jørgensen JB
Vaccine; 2012 Jul; 30(32):4828-34. PubMed ID: 22634299
[TBL] [Abstract][Full Text] [Related]
23. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice.
Kiyotani K; Sakaguchi T; Kato A; Nagai Y; Yoshida T
Virology; 2007 Mar; 359(1):82-91. PubMed ID: 17027894
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins.
Zheng M; Jin N; Liu Q; Huo X; Li Y; Hu B; Ma H; Zhu Z; Cong Y; Li X; Jin M; Zhu G
Virology; 2009 Aug; 391(1):33-43. PubMed ID: 19559453
[TBL] [Abstract][Full Text] [Related]
25. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
26. Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity.
Tannis LL; Gauthier A; Evelegh C; Parsons R; Nyholt D; Khromykh A; Bramson JL
Vaccine; 2005 Jul; 23(33):4189-94. PubMed ID: 16005737
[TBL] [Abstract][Full Text] [Related]
27. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
[TBL] [Abstract][Full Text] [Related]
28. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
29. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines.
Fernández IM; Harmsen M; Benaissa-Trouw BJ; Stuij I; Puyk W; Meloen RH; Snippe H; Kraaijeveld CA
Vaccine; 1998 Oct; 16(16):1531-6. PubMed ID: 9711800
[TBL] [Abstract][Full Text] [Related]
30. The amino-terminal domain of bovine viral diarrhea virus Npro protein is necessary for alpha/beta interferon antagonism.
Gil LH; Ansari IH; Vassilev V; Liang D; Lai VC; Zhong W; Hong Z; Dubovi EJ; Donis RO
J Virol; 2006 Jan; 80(2):900-11. PubMed ID: 16378992
[TBL] [Abstract][Full Text] [Related]
31. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.
Szomolanyi-Tsuda E; Brien JD; Dorgan JE; Garcea RL; Woodland RT; Welsh RM
Virology; 2001 Feb; 280(2):160-8. PubMed ID: 11162830
[TBL] [Abstract][Full Text] [Related]
32. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice.
Schijns VE; Haagmans BL; Horzinek MC
J Immunol; 1995 Sep; 155(5):2525-32. PubMed ID: 7650382
[TBL] [Abstract][Full Text] [Related]
33. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
[TBL] [Abstract][Full Text] [Related]
34. Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.
García AD; Meseda CA; Mayer AE; Kumar A; Merchlinsky M; Weir JP
Clin Vaccine Immunol; 2007 Aug; 14(8):1032-44. PubMed ID: 17596428
[TBL] [Abstract][Full Text] [Related]
35. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
Balcarova J; Helenius A; Simons K
J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
[TBL] [Abstract][Full Text] [Related]
36. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.
Price GE; Gaszewska-Mastarlarz A; Moskophidis D
J Virol; 2000 May; 74(9):3996-4003. PubMed ID: 10756011
[TBL] [Abstract][Full Text] [Related]
37. Role of interferon-gamma and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection.
Keogh B; Atkins GJ; Mills KH; Sheahan BJ
Neuropathol Appl Neurobiol; 2003 Dec; 29(6):553-62. PubMed ID: 14636162
[TBL] [Abstract][Full Text] [Related]
38. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling.
Partidos CD; Weger J; Brewoo J; Seymour R; Borland EM; Ledermann JP; Powers AM; Weaver SC; Stinchcomb DT; Osorio JE
Vaccine; 2011 Apr; 29(16):3067-73. PubMed ID: 21300099
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy.
Day SL; Ramshaw IA; Ramsay AJ; Ranasinghe C
J Immunol; 2008 Jun; 180(11):7158-66. PubMed ID: 18490714
[TBL] [Abstract][Full Text] [Related]
40. Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity.
Xu D; Holko M; Sadler AJ; Scott B; Higashiyama S; Berkofsky-Fessler W; McConnell MJ; Pandolfi PP; Licht JD; Williams BR
Immunity; 2009 Jun; 30(6):802-16. PubMed ID: 19523849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
